{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:57:12Z","timestamp":1760821032871,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare, Japan","doi-asserted-by":"publisher","award":["150401-01","180101-01"],"award-info":[{"award-number":["150401-01","180101-01"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI","award":["JP16H05345","JP18H02782","JP17K10008"],"award-info":[{"award-number":["JP16H05345","JP18H02782","JP17K10008"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbrc.2018.08.193","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:21:07Z","timestamp":1536240067000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22"],"prefix":"10.1016","volume":"504","author":[{"given":"Toshihiro","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Wilson","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam H.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikao","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.08.193_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.08.193_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2012.12.005","article-title":"Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies","volume":"34","author":"Haas","year":"2013","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.bbrc.2018.08.193_bib3","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-11-1990","article-title":"CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma","volume":"18","author":"Aoe","year":"2012","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2018.08.193_bib4","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/bjc.2014.151","article-title":"Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma","volume":"110","author":"Yamamoto","year":"2014","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.bbrc.2018.08.193_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086671","article-title":"CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells","volume":"9","author":"Okamoto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.08.193_bib6","first-page":"2031","article-title":"In\u00a0vitro and in\u00a0vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299","volume":"7","author":"Ho","year":"2001","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2018.08.193_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2567.2002.01510.x","article-title":"G1\/S cell cycle arrest provoked in human T cells by antibody to CD26","volume":"107","author":"Ohnuma","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2018.08.193_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12935-016-0310-9","article-title":"A\u00a0humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2\/M cell cycle transition","volume":"16","author":"Hayashi","year":"2016","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.bbrc.2018.08.193_bib9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/bjc.2017.62","article-title":"First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers","volume":"116","author":"Angevin","year":"2017","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.bbrc.2018.08.193_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","article-title":"The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression","volume":"29","author":"Zhang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2018.08.193_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molcel.2008.01.007","article-title":"Dubbing SAGA unveils new epigenetic crosstalk","volume":"29","author":"Pijnappel","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2018.08.193_bib12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4161\/cc.7.11.5962","article-title":"USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A","volume":"7","author":"Zhang","year":"2008","journal-title":"Cell Cycle"},{"issue":"Suppl","key":"10.1016\/j.bbrc.2018.08.193_bib13","first-page":"OL1803","article-title":"Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest","volume":"58","author":"Ling","year":"2012","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.08.193_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1158\/0008-5472.CAN-13-1954","article-title":"USP22 regulates oncogenic signaling pathways to drive lethal cancer progression","volume":"74","author":"Schrecengost","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.08.193_bib15","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","article-title":"Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors","volume":"13","author":"Inamoto","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2018.08.193_bib16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-06-1638","article-title":"Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells","volume":"67","author":"Ohnuma-Ishikawa","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.08.193_bib17","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.4049\/jimmunol.167.12.6745","article-title":"Soluble CD26\/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs","volume":"167","author":"Ohnuma","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2018.08.193_bib18","doi-asserted-by":"crossref","first-page":"14186","DOI":"10.1073\/pnas.0405266101","article-title":"CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1","volume":"101","author":"Ohnuma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2018.08.193_bib19","doi-asserted-by":"crossref","first-page":"31191","DOI":"10.18632\/oncotarget.9098","article-title":"Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.08.193_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2012.02.054","article-title":"Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells","volume":"419","author":"Yamazaki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.08.193_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2010.12.054","article-title":"Identification of cancer stem cell markers in human malignant mesothelioma cells","volume":"404","author":"Ghani","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.08.193_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2011.04.098","article-title":"Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia","volume":"409","author":"Yamazaki","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.08.193_bib23","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI23412","article-title":"Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer","volume":"115","author":"Glinsky","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.08.193_bib24","first-page":"1369","article-title":"Overexpression of CD26\/DPPIV in mesothelioma tissue and mesothelioma cell lines","volume":"26","author":"Amatya","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2018.08.193_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062304","article-title":"Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription","volume":"8","author":"Yamada","year":"2013","journal-title":"PLoS One"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1831893X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1831893X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T03:10:45Z","timestamp":1604891445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1831893X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0006291X1831893X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.193","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}